跳至主要内容
临床试验/ACTRN12620001305910
ACTRN12620001305910已完成未知

ß-Hydroxy-ß-Methylbutrate (HMB) supplementation and functional outcomes in multi-trauma patients: A feasibility and pilot randomised controlled trial

The Royal Melbourne Hospital0 个研究点目标入组 51 人开始时间: 2020年12月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • a.Adults, 18 years of age and older
  • b.Completed two full calendar days in ICU
  • c.The predominant reason for ICU admission was a traumatic injury
  • d.Allowed enteral/ oral nutrition at the time of randomization
  • Inclusion criteria for the muscle biopsy sub group as above.

排除标准

  • a. Death during ICU admission deemed to be inevitable
  • b. Bilateral above knee amputation
  • c. Patients assessed as requiring completely or predominantly parenteral nutrition
  • d. Pregnancy
  • e. Primary neuromuscular pathology present or strongly suspected this admission episode
  • f. Presumed transection of the spinal cord at any level
  • g. Medical decision treatment maker, participant or medical practitioner declined consent
  • h. Limited research availability over enrolment timeframe
  • I. Enrollment conflict with other research studies
  • j. Unlikely to be able to participate in long term follow up measures
  • k. Unable to obtain consent within 7 days from initial traumatic injury
  • Additional exclusion criteria for the muscle biopsy sub-group:
  • g.Not mechanically ventilated at the time of enrollment or predicted to be extubated within 48 hours of enrollment.
  • h.Present or strongly suspected disseminated cancer of any kind
  • i.Bleeding diathesis (corrected INR > 1.5 and/or APTT > 50 sec), or receiving any anticoagulant medication beyond that required for venous thromboembolism prophylaxis, or any antiplatelet drug other than low dose aspirin

研究者

相似试验

招募中
不适用
Effect of beta-hydroxy-beta-methylbutyrate (HMB) enriched oral nutrition supplement on surgical outcomes and physical performance in colorectal cancer patients: a randomized Controlled Trialcolorectal cancer patients who underwent elective colorectal cancer surgerycolorectal cancer, beta-hydroxy-beta-methylbutyrate (HMB) enriched oral supplement, Enhanced Recovery after Surgery (ERAS), physical performance
TCTR20220606005Siriraj hospital Mahidol university52
已完成
4 期
The effect of beta-hydroxy-beta-methylbutyrate with resistance training on the skeletal muscle and the skin in postmenopausal women: A preliminary trialpostmenopausal
JPRN-UMIN000028142Faculty of Health and Sport Sciences, University of Tsukuba60
Unknown
2 期
HMB and Exercise-induced Muscle DamageSupplementationSportSports NutritionMuscle DamageRecovery
NCT04549610Poznan University of Physical Education30
已完成
1 期
Effects of beta-hydroxy-beta-methylbutyrate supplementation in decompensated cirrhosis patients with sarcopenia: Randomize controlled trial, Preliminary StudyDecompensated cirrhosis is associated with poor outcomes, especially when combined with sarcopenia.Cirrhosis, Sarcopenia, Beta-hydroxy beta-methylbutyrate
TCTR20240422012Khon Kaen University23
已完成
3 期
effect of ß-Hydroxybutyrate and HIIT on gene expressions of Klotho/FGF axis an inflammatiobeta hydroxybutyrate, ketone body, Klotho, FGF23, FGF21, HIIT, high intensity interval, aging.
IRCT20221106056419N1Shahid Beheshti University of Medical Sciences30